期刊文献+

血清血管内皮生长因子和白细胞介素-6在多发性骨髓瘤中的临床意义 被引量:2

Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma
下载PDF
导出
摘要 目的:探讨多发性骨髓瘤(MM)和实体瘤骨转移患者血清血管内皮生长因子(VEGF)和白细胞介素 (IL) 6水平变化的临床意义。方法:MM组37例,其中临床Ⅰ期7例,Ⅱ期8例,Ⅲ期22例;实体瘤骨转移阳性对 照组8例和正常对照组17例;用ELISA方法检测血清VEGF和IL 6的水平。结果:MM组和实体瘤骨转移组血清 VEGF和IL 6水平明显高于正常对照组(P<0.01),且MM组的VEGF水平明显高于实体瘤骨转移组(P<0.05)。 随着临床分期增加,VEGF和IL 6水平呈递增趋势,VEGF水平在Ⅲ期高于Ⅰ期组和Ⅱ期组(P<0.05),IL 6在Ⅱ期 组高于Ⅰ期组(P<0.05)。各骨损评分组间IL 6水平差异存在显著性(P<0.05)。VEGF与血肌苷,尿轻链λ存 在密切的关系(P<0.01);IL 6与血钙,C反应蛋白存在密切的关系(P<0.01)。IL 6水平在临床参数C反应蛋 白、血钙、β2微球蛋白异常组高于其正常组(P<0.05);而VEGF水平在血肌苷、血轻链λ、尿轻链λ的异常组高于 其正常组(P<0.05)。结论:检测血清VEGF和IL 6水平对于MM患者的诊断及鉴别诊断、临床分期、骨损程度和 病情的判断具有重要意义。 Objective To investigate the clinical significance of the changes of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) level in multiple myeloma (MM), solid tumor fo- llowing bone metastasis. Methods Thirty- seven MM patients, including 7 in StageⅠ, 8 in StageⅡ, 22 in Stage Ⅲ, 8 solid tumor with bone metastasis patientsly, and 17 healthy controls were enrolled in this study. The serum VEGF and IL-6 levels were determined by ELISA. Results Serum VEGF and IL-6 concentrations in patients with MM and solid tumor were significantly higher than those of the healthy controls (P<0.01), and the VEGF level was higher in MM than in solid tumor with bone metastasis. There was significant difference in VEGF and IL-6 levels in various clinical stages of MM. VEGF levels in StageⅢ were significantly higher than in StageⅠ(P<0.05) and IL-6 levels in StageⅡwere significantly higher than in StageⅠ(P<0.05). The levels of IL-6 showed great difference according to bone lesion scores (P<0.05). There was a positive correlation between IL-6 and serum calcium or C-reactive protein(P<0.01), and there was a positive correlation between VEGF and serum Cr or urinary Bene-Jones protein λ (P<0.01). The IL-6 levels had significant differences between patients with the normal serum CRP, serum calcium, and β 2-MG and patients with abnormal ones (P<0.05). VEGF levels showed significant differences between the patients with normal serum Cr, serum calcium Bene-Jones protein λ, and urinary Bene-Jones protein λ and patients with abnormal ones (P<0.05). Conclusion Serum VEGF and IL-6 levels are helpful to diagnose the clinical stages, and understand bone lesion and serevity of MM.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第1期68-71,共4页 Journal of Central South University :Medical Science
基金 湖南省卫生厅医学科研基金(Y03 060)
关键词 多发性骨髓瘤 血管内皮生长因子 白细胞介素-6 血管生成因子 multiple myeloma vascular endothelial growth factor interleukin-6
  • 相关文献

参考文献11

  • 1Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis[J]. N Eng J Med, 1995,333(26): 1757-1763.
  • 2Frassanito MA, Cusmai A, Lodice G, et al. Interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis [J]. Blood, 2001, 97(2):483-489.
  • 3Spets H, Stromberg T, Georgii-Hemming P, et al. Expression of the bcl-2 family of pro- and anti-apoptosis genes in multiple myeloma and normal plasma cells:regulation during interleuin-6(IL-6)-induced growth and survival[J]. Eur J Haematol, 2002,69(2): 76-89.
  • 4Dankbar B, Padro T, Leo R, et al.Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma[J]. Blood, 2000, 95(11):2630-2636.
  • 5Alexandrakis MG, Passam FH, Sfiridaki A, et al. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease acticvity[J]. Am J Hematol, 2003, 72(4): 229-233.
  • 6张静楠,董作仁,郭晓楠,林凤茹,杜行严,姚尔固.急性白血病患者血管内皮生长因子及其受体表达的临床意义[J].临床血液学杂志,2003,16(6):262-264. 被引量:8
  • 7陈文明,吴垠,朱嘉芷,Jeannette Soria,Massoud Mirshahi.多发性骨髓瘤血管新生的体外研究[J].中国实验血液学杂志,2002,10(4):310-314. 被引量:4
  • 8Moehler TM, Ho AD, Goldschmidt H. Angiogenesis in hematologic malignancies[J]. Crit Rev Oncol Hematol, 2003, 45(3):227-244.
  • 9Kumar S, Witzig TE, Timm M, et al.Expression of VEGF and its recptors by myeloma cells[J]. Leukemia, 2003,17(10):2025-2031.
  • 10Turensson I, Abildgard N, Ahlgren T, et al.Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors[J]. Br J Hameatol,1999, 106(4):1005-1012.

二级参考文献26

  • 1Chimczynski P, Sacchi N. Single-step method of RNA isolation by acidguanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem, 1987, 162:156-160.
  • 2Hussong J W, Rodgers G M, Shami P J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood, 2000, 95:309-313.
  • 3Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 1997, 89:1870-1875.
  • 4Noonan K E, Beck C, Holzmayer T A, et al. Quantitative analysis of mdrl (multidrug resistance) gene expression in human tumors by polymerase chine reaction.Proc Natl Acad Sci USA, 1990, 87:7100-7106.
  • 5Bellamy W T, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res, 1999, 59:728-733.
  • 6Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000, 96:2240-2245.
  • 7Zachary I. Molecules in focus vascular endothelial growth factor. IJBCB, 1998, 30:1169-1174.
  • 8Dias S, Koichi H, Zhu Z, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 2000, 106:511-521.
  • 9Ratajczak M Z, Ratajczak J, Machalinski B, et al. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (P1GF) in regulating human haemopoietic cell growth. Br J Haematol, 1998, 103:969-979.
  • 10Di Raimondo F, Azzaro MP, Palumbo G, et al. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica, 2000; 85: 800 - 805

共引文献9

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部